Cargando…

Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging

BACKGROUND/AIMS: This study aimed to compare the diagnostic performances of Liver Imaging Reporting and Data System (LI-RADS) 2018 and Korean Liver Cancer Association-National Cancer Center (KLCA-NCC) 2018 criteria on magnetic resonance imaging (MRI) for the noninvasive diagnosis of hepatocellular c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sunyoung, Kim, Seung-seob, Chang, Dong ryul, Kim, Hyerim, Kim, Myeong-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364353/ https://www.ncbi.nlm.nih.gov/pubmed/32492765 http://dx.doi.org/10.3350/cmh.2020.0004

Ejemplares similares

Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
por: Yoon, Ja Kyung, et al.
Publicado: (2023)

Diagnostic Performance of LI-RADS v2018 versus KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging with Hepatobiliary Agent: A Systematic Review and Meta-Analysis of Comparative Studies
por: Shin, Jaeseung, et al.
Publicado: (2023)

Diagnostic Performance of KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis
por: Kim, Dong Hwan, et al.
Publicado: (2021)

Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018
por: Lee, Sang Min, et al.
Publicado: (2021)

Impact of the updated KLCA-NCC criteria for diagnosis of “probable HCC” in liver MRI: comparisons between KLCA v2022 and v2018
por: Yoon, Jeong Hee
Publicado: (2023)

Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
por: Kang, Hyo-Jin, et al.
Publicado: (2023)

2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Publicado: (2022)

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Publicado: (2022)

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Publicado: (2023)

LI-RADS Version 2018 Treatment Response Algorithm: Diagnostic Performance after Transarterial Radioembolization for Hepatocellular Carcinoma
por: Yoon, Jongjin, et al.
Publicado: (2021)

Validation of the Korean Liver Cancer Association-National Cancer Center 2018 Criteria for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using Magnetic Resonance Imaging
por: Lee, Sunyoung, et al.
Publicado: (2020)

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
por: Kim, Tae-Hyung, et al.
Publicado: (2019)

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2021)

CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
por: Caraiani, Cosmin, et al.
Publicado: (2021)

MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma
por: Zhou, Changwu, et al.
Publicado: (2021)

MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018
por: Zhang, Haiping, et al.
Publicado: (2022)

Man or machine? Prospective comparison of the version 2018 EASL, LI-RADS criteria and a radiomics model to diagnose hepatocellular carcinoma
por: Jiang, Hanyu, et al.
Publicado: (2019)

Functional comparison of anti-restriction and anti-methylation activities of ArdA, KlcA, and KlcA(HS) from Klebsiella pneumoniae
por: Chen, Huimin, et al.
Publicado: (2022)

Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC
por: Erkan, Burcu, et al.
Publicado: (2019)

Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection
por: Shao, Shuo, et al.
Publicado: (2020)

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
por: Huang, Zhe, et al.
Publicado: (2023)

Should Threshold Growth Be Considered a Major Feature in the Diagnosis of Hepatocellular Carcinoma Using LI-RADS?
por: Park, Jae Hyon, et al.
Publicado: (2021)

The value of the apparent diffusion coefficient value in the Liver Imaging Reporting and Data System (LI-RADS) version 2018
por: Saleh, Gehad Ahmad, et al.
Publicado: (2022)

Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI
por: Liu, Xinai, et al.
Publicado: (2022)

Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization
por: Bartnik, Krzysztof, et al.
Publicado: (2021)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update
por: Granata, Vincenza, et al.
Publicado: (2017)

Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort study
por: Bartnik, Krzysztof, et al.
Publicado: (2021)

Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma
por: Wang, Ruizhi, et al.
Publicado: (2023)

Interrater reliability and agreement of the liver imaging reporting and data system (LI-RADS) v2018 for the evaluation of hepatic lesions
por: Abdelrahman, Ahmed S., et al.
Publicado: (2022)

Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation
por: Zhang, Yun, et al.
Publicado: (2020)

Journal of Cardiovascular Magnetic Resonance: 2017/2018 in review
por: Manning, Warren J.
Publicado: (2019)

Anti-Restriction Protein, KlcA(HS), Promotes Dissemination of Carbapenem Resistance
por: Liang, Wei, et al.
Publicado: (2017)

Korea hypertension fact sheet 2018
por: Kim, Hyeon Chang, et al.
Publicado: (2018)

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Publicado: (2015)

Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
por: Zhang, Tong, et al.
Publicado: (2019)

Automated CT LI-RADS v2018 scoring of liver observations using machine learning: A multivendor, multicentre retrospective study
por: Mulé, Sébastien, et al.
Publicado: (2023)

Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm
por: An, Chansik, et al.
Publicado: (2016)

Differentiation of small (≤ 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI-based radiomics analysis to LI-RADS version 2018 algorithm
por: Zhong, Xi, et al.
Publicado: (2021)

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
por: Moura Cunha, Guilherme, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8dsirvqug0q52o62accgspp8tj